Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04718610Terminated
Randomised, open-label trial in lung cancer, colorectal cancer (CRC), multiple myeloma (MM) and 1 more (2 arms), sponsored by Centre Hospitalier d'Avignon. Primary endpoint: Standard Deviation of all NN intervals at 84 days. Started Jan 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04718610.